Author: Priyanka Roy
India’s increase story continues: RBI bulletin projects 7.2% GDP for 2024-25
Confirming the strength of India’s economic growth, the Reserve Bank of India’s October bulletin projected real GDP growth at 7.2 percent for FY 2024-25. In [more…]
HDFC Bank’s FY26 growth to be slightly higher than market growth
HDFC Bank reported a net profit of Rs 17,600 crore, a 17.4 per cent year-on-year growth in advances for the quarter ended September 30, 2024. [more…]
L&T Finance Q2 net profit rises 16.8% to Rs 695 crore, total revenue up 25%
L&T Finance Limited reported its financial results for the quarter ended September 30, 2024, with total revenue from operations growing 25% year-on-year to ₹4,019.34 crore [more…]
Hindustan Zinc Q2 results preview: Profit may rise 30-36%; higher zinc, silver prices to drive sales growth
Hindustan Zinc Ltd (HZL) is set to announce its results for the September 2024 quarter (Q2FY25) and first half of current fiscal year (H1FY25) on [more…]
RIL Q2 net profit drops 5% due to weak performance in O2C business
Reliance Industries Ltd reported consolidated net profit in the second quarter declined by 4.77% to ₹ 16,563 crore from ₹ 17,394 crore in the same [more…]
Hathway Cable shares jump 3% after Q2 profit, revenue rise
Shares of Hathway Cable & Datacom rallied over 3 per cent on October 14 after the cable television distribution company reported strong earnings for the [more…]
Thalassemia, TB, asthma medicines prices likely to increase
New Delhi: Prices of several essential medicines used in the treatment of ailments such as asthma, glaucoma, thalassemia, tuberculosis and mental health disorders are expected [more…]
HDFC Bank shares expansion 2% ahead of Q2 results. What should investors do?
Shares of HDFC Bank, the country’s largest private lender, jumped over 2% in early trade as it prepares to announce its Q2 results on October [more…]
Rupee increase 2 paise to 83.97 in early trade
Foreign institutional investors (FIIs) were net sellers in the capital market on Friday, selling shares worth Rs 9,896.95 crore on a net basis in the [more…]
Natco Pharma shares rise 4% on settlement order in US patent case on generic Ozempic
Natco Pharma rallied 4 percent in morning trade on October 7 following the issuance of a settlement order in the United States patent case on [more…]